| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 95,859 | 99,485 | 83,333 | 106,215 | | Cost of Revenue | 37,395 | 35,780 | 33,518 | 37,694 | | | Gross Profit | 58,464 | 63,705 | 49,815 | 68,521 | | | Operating Expenses | | Research Development | 12,495 | 12,664 | 12,573 | 13,670 | | Selling General and Administrative | 28,193 | 27,840 | 25,278 | 30,537 | | Non Recurring | 2,543 | 2,732 | 1,430 | 29,488 | | Others | 5,753 | 6,051 | 6,076 | 6,826 | | | | Total Operating Expenses | 48,984 | 49,287 | 45,357 | 80,521 | | | | Operating Income or Loss | 9,480 | 14,418 | 4,458 | (12,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,006 | 123 | (243) | (4,628) | | Earnings Before Interest And Taxes | 10,486 | 14,541 | 4,215 | (16,628) | | Interest Expense | 346 | 386 | 239 | 3,036 | | Income Before Tax | 10,140 | 14,155 | 3,976 | (19,664) | | Income Tax Expense | 3,877 | 5,220 | 1,332 | (6,117) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,263 | 8,935 | 2,644 | (13,547) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,263 | 8,935 | 2,644 | (13,547) | | Preferred Stock And Other Adjustments | (8,593) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,330) | $8,935 | $2,644 | ($13,547) |
|
0.02% Nasdaq 0.00%
Income Statement
